- Home
- QNCX vs GDL Comparison
QNCX vs GDL Comparison
Compare QNCX & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- GDL
- Stock Information
- Founded
- QNCX 2012
- GDL 2006
- Country
- QNCX United States
- GDL United States
- Employees
- QNCX N/A
- GDL N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- GDL Investment Managers
- Sector
- QNCX Health Care
- GDL Finance
- Exchange
- QNCX Nasdaq
- GDL Nasdaq
- Market Cap
- QNCX 100.4M
- GDL 95.6M
- IPO Year
- QNCX 2019
- GDL N/A
- Fundamental
- Price
- QNCX $1.98
- GDL N/A
- Analyst Decision
- QNCX Strong Buy
- GDL
- Analyst Count
- QNCX 6
- GDL 0
- Target Price
- QNCX $8.00
- GDL N/A
- AVG Volume (30 Days)
- QNCX 431.7K
- GDL 11.2K
- Earning Date
- QNCX 11-12-2025
- GDL 01-01-0001
- Dividend Yield
- QNCX N/A
- GDL 6.02%
- EPS Growth
- QNCX N/A
- GDL N/A
- EPS
- QNCX N/A
- GDL N/A
- Revenue
- QNCX N/A
- GDL N/A
- Revenue This Year
- QNCX N/A
- GDL N/A
- Revenue Next Year
- QNCX N/A
- GDL N/A
- P/E Ratio
- QNCX N/A
- GDL N/A
- Revenue Growth
- QNCX N/A
- GDL N/A
- 52 Week Low
- QNCX $0.71
- GDL $7.65
- 52 Week High
- QNCX $2.45
- GDL $8.13
- Technical
- Relative Strength Index (RSI)
- QNCX 62.46
- GDL 48.10
- Support Level
- QNCX $1.82
- GDL $8.43
- Resistance Level
- QNCX $2.01
- GDL $8.60
- Average True Range (ATR)
- QNCX 0.16
- GDL 0.07
- MACD
- QNCX 0.03
- GDL -0.01
- Stochastic Oscillator
- QNCX 64.48
- GDL 44.05
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.